Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
- Press Release
King of Prussia, PA: A comprehensive assessment of risk-based quality management (RBQM) adoption has revealed that...
- Press Release
King of Prussia, PA – March 5, 2024: CluePoints, providers of best-in-class statistical and AI-driven software...
- Featured Article
In an interview with ACT editor Andy Studna at SCOPE, Young, Chief Science Officer, CluePoints discusses...
Source: Applied Clinical Trials
- Featured Article
Central monitoring aims at improving the quality of clinical research by pro-actively identifying risks and remediating...
Source: Springer Link
- Press Release
King of Prussia, PA – February 6, 2024: CluePoints, providers of best-in-class statistical and AI-driven software...
- Featured Article
We spoke with leaders and experts in the Clinical Research community about their predictions for 2024.
...Source: Clinical Research News
- Featured Article
Key risk indicators (KRIs) are commonly used as an important component of central monitoring to enable...
Source: Applied Clinical Trials
- Featured Article
Central monitoring helps sponsors to proactively identify and remediate data quality issues during the conduct of...
Source: Applied Clinical Trials
- Press Release
King of Prussia, PA – October 17, 2023: CluePoints, the premier provider of Risk-Based Study Execution...
- Featured Article
CluePoints Co-Founder and Chief Product & Technology Officer François Torche discusses the challenges of collecting clinical...
Source: DIA
- Featured Article
Artificial intelligence (AI) has massive potential to advance clinical research.
...Source: DIA
- Press Release
King of Prussia, PA – October 12, 2023: CluePoints, the premier provider of Risk-Based Study Execution...
- Press Release
RBQM and AI leader was shortlisted for its Time Similarity Test in the ‘Innovative Clinical Trial...
- Press Release
King of Prussia, PA – April 1st, 2025: CluePoints, provider of leading statistical and AI-driven software...
- Press Release
The Company, along with its Research and Development Teams, were shortlisted for continuing its mission of...
- Press Release
CluePoints Appoints Richard Young as Chief Strategy Officer King of Prussia, PA – October 28th, 2024:...
- Press Release
King of Prussia, PA – October 23rd, 2024: CluePoints, provider of leading statistical and AI-driven software...
- Press Release
CluePoints furthers its commitment to delivering innovative solutions that enhance clinical trial efficiency with this latest...
- Press Release
Site Profile & Oversight Tool (SPOT) and Intelligent Medical Coding (IMC) unveiled by RBQM innovator at...
- Press Release
CluePoints is a cloud-based software platform for Risk-Based Quality Management (“RBQM”) and data quality oversight in...
- Press Release
KING OF PRUSSIA, Pa., — CluePoints, provider of leading statistical and AI-driven software solutions, today unveiled...
- Press Release
King of Prussia, PA: CluePoints, providers of leading statistical and AI-driven software solutions and Food and...
- Press Release
King of Prussia, PA – March 25, 2024: CluePoints, providers of best-in-class statistical and AI-driven software...
- Press Release
King of Prussia, PA: A comprehensive assessment of risk-based quality management (RBQM) adoption has revealed that...
- Featured Article
The ICH E6(R3) draft guideline document, currently open to public consultation, places the industry firmly in...
Source: Applied Clinical Trials
- Featured Article
Despite the push for greater use of risk-based quality management (RBQM) in clinical research, adoption of...
Source: CenterWatch
- Featured Article
Central monitoring aims to detect emerging quality-related risks proactively during a clinical trial, resulting in study...
Source: Applied Clinical Trials
- Featured Article
Using key risk indicators (KRIs) can improve clinical trial data quality in 80% of the sites...
Source: Applied Clinical Trials
- Featured Article
Since the release of ICH E6(R2), multiple efforts have been made to interpret the requirements and...
- Read
Source: Springer Link
- Featured Article
An expectation for the use of quality tolerance limits (QTLs) was formally established in the International...
Source: Applied Clinical Trials
- Featured Article
Clinical research is evolving rapidly, with the digitalization of trials creating a new modus operandi and...
Source: Applied Clinical Trials
- Featured Article
Risk-based approaches to monitoring clinical trials were brought to the forefront with an FDA guidance published...
Source: Applied Clinical Trials
- Featured Article
Key risk indicators (KRIs) are metrics designed to identify risks of specific interest to study teams...
Source: Applied Clinical Trials
- Featured Article
The success of clinical development programmes, drug approval and marketing depends ultimately on the readability and...
Source: International Clinical Trials
- Featured Article
Central monitoring, which typically includes the use of key risk indicators (KRIs), aims at improving the...
Source: Springer Link
- Featured Article
Clinical research is in the grips of a revolution that has caused a wave of new...
Source: ACRP
